Foreword

It is a pleasure to introduce the 12th edition of the BSAVA Small Animal Formulary – Part A: Canine and Feline. This publication remains one of the most trusted and widely used resources in small animal practice, helping clinicians make safe, evidence-based decisions every day.

This new edition continues to evolve with veterinary medicine. It includes new monographs on drugs such as citalopram, enflicoxib, ilunocitinib and venlafaxine, reflecting the expanding range of therapeutic options available to our patients. The addition of new appendices – including a seizure algorithm, detailed guidance on supplements and nutraceuticals, and expanded information on contrast agents – enhances its practical value in daily case management.

The review and update of all 112 client information leaflets, alongside the inclusion of seven new ones, further strengthen the link between practitioner and pet owner, supporting clear communication and responsible medicine use.

The Formulary continues to embody what the BSAVA stands for – scientific rigour, clinical relevance, and a commitment to improving animal welfare. I thank Fergus Allerton and his team who have contributed to this remarkable resource and commend it to you as an essential companion in practice.

Julian Hoad BSc(Hons) BVetMed HonMBVNA MRCVS BSAVA President 2024–2026